CuII(atsm) could also modify TAR-DNA binding protein 43 (TDP-43) metabolism, a protein central to neuropathology of amyotrophic lateral sclerosis and a sub-set of frontotemporal dementia cases [15], [16]. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.